Current Oncology Reports

, Volume 12, Issue 6, pp 352–354

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

Authors

  • Amit Mahipal
    • Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Kimmel Cancer CenterThomas Jefferson University
    • Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Kimmel Cancer CenterThomas Jefferson University
Clinical Trial Report

DOI: 10.1007/s11912-010-0122-3

Cite this article as:
Mahipal, A. & Weiss, M. Curr Oncol Rep (2010) 12: 352. doi:10.1007/s11912-010-0122-3
  • 58 Views

Copyright information

© Springer Science+Business Media, LLC 2010